NEUROTROPIN

What this means for you

Registered since 10 Oct 2000. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 10 Oct 2020).

Record

Serial number

75627101

Registration number

2392807

Mark type

Word mark

Filed

25 Jan 1999

Published for opposition

18 Jul 2000

Registered

10 Oct 2000

Next maintenance due

10 Oct 2020

Attorney of record

Holly M. Ford Lewis

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparation for use in the treatment of pain, neuralgia, [ pruritus, allergic diseases, inflammation, rhinitis, arthritis, peripheral circulatory disturbance, ] coldness, dysesthesia, neuropathy, reflex sympathetic dystrophy, edema, [ dementia, virus disease, distress syndrome, immunodeficiency syndrome, autoimmume diseases, ] autonomic dystonia, [ spiro-cerebellar degeneration or thrombocylopenia ]

Owner

• Nippon Zoki Pharmaceutical Co., Ltd., Osaka-shi, Osaka-fu, JP
• Nippon Zoki Pharmaceutical Co., Ltd., Chuo-ku Osaka-shi, Osaka-fu, JP
• Nippon Zoki Pharmaceutical Co., Ltd., Chuo-ku Osaka-shi, Osaka-fu, JP

Prosecution history

• 29 Oct 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
• 29 Oct 2020 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
• 29 Oct 2020 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
• 29 Oct 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 11 Sept 2020 — TEAS SECTION 8 & 9 RECEIVED
• 10 Oct 2019 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
• 25 Aug 2010 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
• 25 Aug 2010 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
• 12 Aug 2010 — TEAS SECTION 8 & 9 RECEIVED
• 22 May 2008 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 22 May 2008 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 29 Sept 2006 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
• 19 Sept 2006 — ASSIGNED TO PARALEGAL
• 07 Jul 2006 — REGISTERED - SEC. 8 (6-YR) FILED
• 07 Jul 2006 — PAPER RECEIVED